Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 24.83 as of Sunday, July 26, 2026.
Forward PE Ratio (24.83) = Close Price ($477.36) / Consensus Forward EPS ($19.23)
FORWARD PE RATIO
24.83
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+35.06%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$121.16B
Forward PE Ratio
24.83
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $121.16B | 24.83 |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.53B | 31.38 |
| Stryker Corporation (SYK)vs › | $126.60B | 22.05 |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 9.79 |
| Danaher Corporation (DHR)vs › | $134.62B | 22.57 |
| Medtronic plc (MDT)vs › | $106.51B | 15.08 |
| CVS Health Corp. (CVS)vs › | $137.47B | 14.48 |
| GSK plc (GSK)vs › | $103.60B | 14.35 |
| Pfizer Inc. (PFE)vs › | $139.86B | 8.34 |
| McKesson Corporation (MCK)vs › | $98.45B | 21.56 |
Trailing P/E
28.3
reported TTM EPS
Forward P/E
24.8
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $19.23 implies +14.1% EPS growth vs the reported trailing $16.86.
At today's $477.36 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| Fiscal year end |
|---|
| Consensus EPS |
|---|
| Estimate range |
|---|
| Analysts |
|---|
| Implied P/E |
|---|
| 2026-12-31 | $19.23 | $18.87 – $19.71 | 13 | 24.8x |
| 2027-12-31 | $21.40 | $18.40 – $22.48 | 13 | 22.3x |
| 2028-12-31 | $25.39 | $20.50 – $34.00 | 9 | 18.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
